| Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues E Bandrés, E Cubedo, X Agirre, R Malumbres, R Zarate, N Ramirez, ... Molecular cancer 5, 1-10, 2006 | 1127 | 2006 |
| Epigenetic regulation of microRNA expression in colorectal cancer E Bandres, X Agirre, N Bitarte, N Ramirez, R Zarate, J Roman‐Gomez, ... International journal of cancer 125 (11), 2737-2743, 2009 | 552 | 2009 |
| microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells E Bandres, N Bitarte, F Arias, J Agorreta, P Fortes, X Agirre, R Zarate, ... Clinical Cancer Research 15 (7), 2281-2290, 2009 | 499 | 2009 |
| MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells N Bitarte, E Bandres, V Boni, R Zarate, J Rodriguez, M Gonzalez-Huarriz, ... Stem cells 29 (11), 1661-1671, 2011 | 321 | 2011 |
| Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with … MF Sanmamed, S Fernández-Landázuri, C Rodríguez, R Zárate, ... Clinical chemistry 61 (1), 297-304, 2015 | 274 | 2015 |
| miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation V Boni, N Bitarte, I Cristobal, R Zarate, J Rodriguez, E Maiello, ... Molecular cancer therapeutics 9 (8), 2265-2275, 2010 | 200 | 2010 |
| Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan V Boni, R Zarate, JC Villa, E Bandrés, MA Gomez, E Maiello, ... The pharmacogenomics journal 11 (6), 429-436, 2011 | 149 | 2011 |
| Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer J Rodríguez, R Zarate, E Bandres, V Boni, A Hernández, JJ Sola, ... European journal of cancer 48 (12), 1774-1780, 2012 | 101 | 2012 |
| Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma E Bandres, V Catalan, I Sola, B Honorato, E Cubedo, L Cordeu, E Andion, ... Oncology reports 12 (2), 287-292, 2004 | 89 | 2004 |
| Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis R Zarate, J Rodriguez, E Bandres, A Patiño-García, M Ponz-Sarvise, ... British journal of cancer 102 (6), 987-994, 2010 | 76 | 2010 |
| A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients E Bandrés, R Malumbres, E Cubedo, B Honorato, R Zarate, A Labarga, ... Oncology reports 17 (5), 1089-1094, 2007 | 75 | 2007 |
| MicroRNAs as cancer players: potential clinical and biological effects E Bandres, X Agirre, N Ramirez, R Zarate, J Garcia-Foncillas DNA and cell biology 26 (5), 273-282, 2007 | 72 | 2007 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 64 | 2023 |
| Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients E Bandrés, R Barricarte, C Cantero, B Honorato, R Malumbres, R Zárate, ... Oral oncology 43 (7), 713-719, 2007 | 53 | 2007 |
| Novel genes and sex differences in COVID-19 severity R Cruz, S Diz-de Almeida, M López de Heredia, I Quintela, FC Ceballos, ... Human Molecular Genetics 31 (22), 3789-3806, 2022 | 52 | 2022 |
| Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array A Abajo, N Bitarte, R Zarate, V Boni, I Lopez, M Gonzalez-Huarriz, ... World journal of gastroenterology: WJG 18 (7), 637, 2012 | 52 | 2012 |
| Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions N Ramírez, E Bandrés, A Navarro, A Pons, S Jansa, I Moreno, ... European journal of cancer 44 (17), 2689-2695, 2008 | 45 | 2008 |
| Pharmacogenomics in colorectal cancer: the first step for individualized-therapy E Bandrés, R Zárate, N Ramirez, A Abajo, N Bitarte, J García-Foncillas World journal of gastroenterology: WJG 13 (44), 5888, 2007 | 44 | 2007 |
| Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients A Abajo, V Boni, I Lopez, M Gonzalez-Huarriz, N Bitarte, J Rodriguez, ... British journal of cancer 107 (2), 287-290, 2012 | 42 | 2012 |
| Combining chemotherapy and targeted therapies in metastatic colorectal cancer J Rodriguez, R Zarate, E Bandres, A Viudez, A Chopitea, ... World journal of gastroenterology: WJG 13 (44), 5867, 2007 | 39 | 2007 |
